BLAINVILLE, QC, Dec. 10, 2018 /CNW Telbec/ - Duchesnay Inc. is pleased to announce that LadySystem® vaginal cones are now available on Amazon.ca. Since November 1st, 2018, women have had the option to order LadySystem® vaginal cones confidentially, from one of the world's most trusted online retailers.
LadySystem® therapy is indicated for women with a weakened pelvic floor, which may cause urinary stress incontinence (USI), moderate prolapse, and/or reduced sexual sensitivity. To help tone weakened pelvic floor muscles, the Society of Obstetricians and Gynecologists of Canada (SOGC) recommends pelvic floor retraining using vaginal cones as an effective way to reduce embarrassing bladder leaks due to USI.
To use LadySystem®, a cone is inserted into the vagina like a tampon. Once in place, a slight passive and active contraction of the pelvic muscles holds the cone in place while standing, walking or going about daily activities. It is recommended that this exercise be performed for 15 minutes, twice daily, for three months.
LadySystem® vaginal cones are made of hypoallergenic, silicone-free and latex-free, medical grade materials that comply with international standards of pharmacological safety. LadySystem® is also recognized by the SOGC's brand recognition program.
LadySystem® vaginal cones should not be used while a woman has a vaginal or uterine infection. LadySystem® cones are for personal use only. To prevent infections, they should not be shared with others. Before using LadySystem®, women should consult their healthcare provider if they have an intrauterine device (IUD), plan to start using LadySystem® during pregnancy or within six weeks following delivery, have recently had an episiotomy, a Caesarean section, or any other gynecological procedure complication. If in doubt, women should consult their physician before using LadySystem®.
Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women's health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding. Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. For more information about Duchesnay, please visit duchesnay.com
SOURCE Duchesnay inc.
For further information: Alida Alepian, Capital-Image, 514-739-1188, ext. 239, [email protected]